Vas Narasimhan earned a big pay hike when he moved to the CEO's suite at Novartis
It’s unlikely Vas Narasimhan will rank at the top of any 2018 compensation lists for Big Pharma CEOs. But the Novartis helmsman is definitely on a whole new pay scale compared to what he earned as a drug development chief.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.